SCHEMBL20205527

SCHEMBL20205527

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc(-c4ccccc4)c4ccccc14)c1c2oc2ccccc21)C(C)(C)c1cc(-c2ccc(-c4ccccc4)c4ccccc24)c2c(oc4ccccc42)c1-3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.39
▸ CDC14A Q9UNH5 2/20 0.39
▸ PGR P06401 2/20 0.36
▸ ALK Q9UM73 7/20 0.34
▸ CYP19A1 P11511 2/20 0.32
▸ CYP17A1 P05093 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24649891 0.96 CDC14B (0.37) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205307 0.94 CDC14B (0.39) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205310 0.93 CDC14B (0.37) CDC14BCDC14APGRALKCYP19A1
SCHEMBL24649835 0.91 CDC14B (0.39) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205313 0.91 CDC14B (0.38) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205471 0.91 CDC14B (0.40) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205320 0.90 CDC14B (0.37) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205321 0.89 CDC14B (0.35) CDC14BCDC14APGRALKCYP19A1
SCHEMBL23351968 0.88 CDC14B (0.37) CDC14BCDC14APGRALKCYP19A1
SCHEMBL20205391 0.88 ALOX5 (0.41) CDC14BCDC14APGRALKCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885PGR 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback